Skip to Content
Merck
  • Quercetin in hypoxia-induced oxidative stress: novel target for neuroprotection.

Quercetin in hypoxia-induced oxidative stress: novel target for neuroprotection.

International review of neurobiology (2012-07-04)
Anand Kumar Pandey, Ranjana Patnaik, Dafin F Muresanu, Aruna Sharma, Hari Shanker Sharma
ABSTRACT

Oxidative stress in the central nervous system is one of the key players for neurodegeneration. Thus, antioxidants could play important roles in treating several neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and aging-related brain disorders. This review is focused on the new developments in oxidative stress-induced neurodegeneration. Further, based on our own investigations, new roles of quercetin, an antioxidant compound in hypoxia and ischemia induced neuroprotection in relation to suppression of oxidative stress, improvement in behavioral function, reduction in infarct volume, brain swelling, and cellular injury in both in vivo and in vitro models are discussed. Our new findings clearly suggest that antioxidant compounds have potential role in therapeutic strategies to treat neurodegenerative diseases in clinical settings.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Brain Extract from bovine brain, Type I, Folch Fraction I
Sigma-Aldrich
Quercetin, ≥95% (HPLC), solid